Could an ancient mushroom extract extend breast cancer survival?
NCT ID NCT07601113
First seen May 24, 2026 · Last updated May 24, 2026
Summary
This study follows up on 66 breast cancer patients who previously received PG2 (an astragalus extract) alongside chemotherapy. Researchers want to see if PG2 helped delay cancer recurrence or spread, and whether it improved overall survival. The goal is to learn if this natural supplement can offer long-term benefits for early-stage breast cancer patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SURVIVAL are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Chang Gung Memorial Hospital, Kaohsiung Branch
Kaohsiung City, Taiwan
-
Chang Gung Memorial Hospital, Linkou Branch
Taoyuan City, Taiwan
-
Chang Gung Memorial Hospital, Lovers Lake branch
Keelung, Taiwan
-
Chang Gung Memorial Hospital, Taipei Branch
Taipei, Taiwan
-
E-Da Cancer Hospital
Kaohsiung City, Taiwan
Conditions
Explore the condition pages connected to this study.